Skip to content
Home/Companies/HealthTech/PredictImmune

PredictImmune

HealthTech·UK·Exited 2024·Held 5yr
Entry
2019
Hold
5yr
Exit
2024

Who owns PredictImmune?

PredictImmune is a British HealthTech company, formerly owned by Cambridge Innovation Capital, exited in 2024. No current private equity owner is on file.

Hand-verified · updated 2026-06-21

Open JSON · CC-BY
Cambridge Innovation Capital
Investor
Cambridge Innovation Capital
CIC Fund I · 2013 · VC

Key facts

HQUK
SectorHealthTech
StatusAcquired
Exit Year
2024

More from CIC Fund I

Other portfolio companies in the same fund.

Seldon
Seldon
Exited 2026
AI/MLUK· 2020
to TrueFoundry
Gyroscope Therapeutics
Gyroscope Therapeutics
Exited 2021
BiotechUK· 2019
to Novartis
Sense Biodetection
Sense Biodetection
Exited 2023
MedTechUK· 2019
to Sherlock Biosciences
Audio Analytic
Exited 2022
AI/MLUK· 2017
to Meta
Cytora
Cytora
Exited 2025
InsurTechUK· 2017
to Applied Systems
Riverlane
Riverlane
Active
Deep TechUK· 2017

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns PredictImmune?

PredictImmune was formerly owned by Cambridge Innovation Capital, exited in 2024. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue